GLP Watchdog

Gala vs RxSpan MD

Neither Gala nor RxSpan MD has an FDA warning letter on record. On compounded tirzepatide injection, Gala costs $1,800 less a year at standing rates: $179 a month against $329 a month at RxSpan MD. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gala / RxSpan MD

Gala logo

Gala

8.5/10

RxSpan MD logo

RxSpan MD

7.9/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$249/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Gala
Visit RxSpan MD

Both Gala and RxSpan MD are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Gala 8.5, RxSpan MD 7.9). How we are paid

What the record shows

  1. 01

    Neither Gala nor RxSpan MD has an FDA warning letter on record.

  2. 02

    RxSpan MD names four pharmacies. Gala names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, Gala costs $1,800 less a year at standing rates: $179 a month against $329 a month at RxSpan MD. It is one of two products the two sell at comparable terms.

  4. 04

    Only RxSpan MD lists a price for brand-name tirzepatide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gala

RxSpan MD

Compounded semaglutide injection

$179/moLower

$2,148 a year

$249/mo

$2,988 a year

Compounded tirzepatide injection

$179/moLower

$2,148 a year

$329/mo

$3,948 a year

Brand-name semaglutide pen

$1,299/mo

$15,588 a year

$1,299/mo

$15,588 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,069/mo

$12,828 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
None
Refunds
No refund on cancellation; full refund only if the medical provider disqualifies you
Not stated
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Gala: October 17, 2026. RxSpan MD: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gala

8.5/10
  • $840 a year less on compounded semaglutide injection
  • $1,800 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy
Visit Gala

The case for RxSpan MD

7.9/10
  • Sells brand-name tirzepatide pen, which Gala does not price
  • Names its compounding pharmacy
Visit RxSpan MD

Scores

Gala 8.5 · RxSpan MD 7.9 out of 10. Six weighted parts.

Value25%

7.9A
vs
B
3.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
10.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

The score is the same formula for every seller. Payment does not enter it. Method

Gala vs RxSpan MD: questions

Neither Gala nor RxSpan MD has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
RxSpan MD names four pharmacies. Gala names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Gala, by $840 a year at standing rates. Gala: $179 a month, about $2,148 a year. RxSpan MD: $249 a month, about $2,988 a year.
Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you. RxSpan MD states you can cancel at any time.
Both Gala and RxSpan MD are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Gala 8.5, RxSpan MD 7.9).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks